SPIKEVAX BIVALENT ORIGINAL/OMICRON (ELASOMERAN/IMELASOMERAN) COVID-19 VACCINE
SPIKEVAX BIVALENT ORIGINAL/OMICRON (elasomeran/imelasomeran) COVID-19 Vaccine has provisional approval for the indication below:
As a booster dose for active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 18 years of age and older.
Product Information
Product Information
Consumer Medicine Information
Consumer Medicine Information
Spikevax (previously COVID‑19 Vaccine Moderna)
SPIKEVAX (elasomeran) COVID-19 Vaccine has provisional approval for the indication below:
Active immunisation to prevent coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 in individuals 6 months of age and older.
Product Information
Product Information
Consumer Medicine Information
Consumer Medicine Information
Contact Moderna
8am-5pm AEST Mon-Fri
APACMedInfo@modernatx.com